Gpn Vaccines
Funding and backers
Total raised
$3.5M
1 round on record
Latest round
$3.5M
Venture round · Dec 2025 · 10 mo ago
Team
11-50
employees, estimated range
The money's age
Fresh money
10 months since the last round · not hiring
Momentum
35/100
in the news, fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Dec 2025 | $3.5M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | GPN VACCINES, INC. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Timothy HirstExecutive Officer, DirectorSEC Form D
James SelkirkExecutive OfficerSEC Form D
Financials
Total raised
$3.5M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2025 | $3.5M | Details |
People
Timothy Hirst
Executive Officer, Director
James Selkirk
Executive Officer
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
News
GPN Vaccines Raises $10 Million To Advance Gamma-PN Pneumococcal Vaccine Toward Phase 2 Trials
GPN Vaccines, a clinical-stage biotechnology company developing broadly protective bacterial vaccines, has closed a fully subscribed $10 million private placement with participation from new and existing investors. The financing will support preparations
Read more
Report
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Wilmington
United States
HQ
10-50 est. staff